South Korea’s pharma industry has a valuable pool of promising drugs, but China still leads the way in out-licensing deals.

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed ...

It will also push ahead with plans to make innovative and modern healthcare within Asia’s reach, says its chief executive ...

The FDA has agreed to fast-track its review of gepotidacin, an oral antibiotic already approved for urinary tract infections, ...